NASDAQ
MMSI

Merit Medical Systems Inc

Medical Instruments & Supplies
Healthcare

Prices are adjusted according to historical splits.

Merit Medical Systems Inc Stock Price

Vitals

Today's Low:
$65.05
Today's High:
$66.47
Open Price:
$65.89
52W Low:
$52.79
52W High:
$85.62
Prev. Close:
$65.97
Volume:
268984

Company Statistics

Market Cap.:
$3.78 billion
Book Value:
20.885
Revenue TTM:
$1.20 billion
Operating Margin TTM:
9.19%
Gross Profit TTM:
$519.10 million
Profit Margin:
7.48%
Return on Assets TTM:
3.97%
Return on Equity TTM:
7.87%

Company Profile

Merit Medical Systems Inc had its IPO on 1990-08-09 under the ticker symbol MMSI.

The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Merit Medical Systems Inc has a staff strength of 6,846 employees.

Stock update

Shares of Merit Medical Systems Inc opened at $65.89 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $65.05 - $66.47, and closed at $66.13.

This is a +0.24% increase from the previous day's closing price.

A total volume of 268,984 shares were traded at the close of the day’s session.

In the last one week, shares of Merit Medical Systems Inc have increased by +1.27%.

Merit Medical Systems Inc's Key Ratios

Merit Medical Systems Inc has a market cap of $3.78 billion, indicating a price to book ratio of 3.8124 and a price to sales ratio of 3.5688.

In the last 12-months Merit Medical Systems Inc’s revenue was $1.20 billion with a gross profit of $519.10 million and an EBITDA of $193.29 million. The EBITDA ratio measures Merit Medical Systems Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Merit Medical Systems Inc’s operating margin was 9.19% while its return on assets stood at 3.97% with a return of equity of 7.87%.

In Q2, Merit Medical Systems Inc’s quarterly earnings growth was a positive 29.7% while revenue growth was a positive 8.5%.

Merit Medical Systems Inc’s PE and PEG Ratio

Forward PE
25.3165
Trailing PE
42.2581
PEG
2.202

Its diluted EPS in the last 12-months stands at $1.55 per share while it has a forward price to earnings multiple of 25.3165 and a PEG multiple of 2.202. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Merit Medical Systems Inc’s profitability.

Merit Medical Systems Inc stock is trading at a EV to sales ratio of 3.8613 and a EV to EBITDA ratio of 25.6916. Its price to sales ratio in the trailing 12-months stood at 3.5688.

Merit Medical Systems Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$1.84 billion
Total Liabilities
$190.00 million
Operating Cash Flow
$-142895000.00
Capital Expenditure
$5.50 million
Dividend Payout Ratio
0%

Merit Medical Systems Inc ended 2024 with $1.84 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.84 billion while shareholder equity stood at $1.20 billion.

Merit Medical Systems Inc ended 2024 with $34.90 million in deferred long-term liabilities, $190.00 million in other current liabilities, 691523000.00 in common stock, $521.72 million in retained earnings and $381.77 million in goodwill. Its cash balance stood at $72.08 million and cash and short-term investments were $72.08 million. The company’s total short-term debt was $15,281,000 while long-term debt stood at $335.23 million.

Merit Medical Systems Inc’s total current assets stands at $594.91 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $187.99 million compared to accounts payable of $61.76 million and inventory worth $305.94 million.

In 2024, Merit Medical Systems Inc's operating cash flow was $-142895000.00 while its capital expenditure stood at $5.50 million.

Comparatively, Merit Medical Systems Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$66.13
52-Week High
$85.62
52-Week Low
$52.79
Analyst Target Price
$91.63

Merit Medical Systems Inc stock is currently trading at $66.13 per share. It touched a 52-week high of $85.62 and a 52-week low of $85.62. Analysts tracking the stock have a 12-month average target price of $91.63.

Its 50-day moving average was $72.9 and 200-day moving average was $74.47 The short ratio stood at 2.49 indicating a short percent outstanding of 0%.

Around 222.2% of the company’s stock are held by insiders while 9670.9% are held by institutions.

Frequently Asked Questions About Merit Medical Systems Inc

The stock symbol (also called stock or share ticker) of Merit Medical Systems Inc is MMSI

The IPO of Merit Medical Systems Inc took place on 1990-08-09

Similar Industry Stocks (Medical Instruments & Supplies)

Last Price
Chg
Chg%
$0.05
0
0%
$791.9
-16.8
-2.08%
$74.51
-5.92
-7.36%
$10.36
-0.54
-4.95%
$545
-26.7
-4.67%
$1722.2
-70.5
-3.93%
$34.22
0.39
+1.15%
$2.53
0.06
+2.43%
$2.56
0.42
+19.63%
INDIANIVESH LTD. (INDIANVSH)
$37.01
-0.95
-2.5%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. It operates in two segments, Cardiovascular and Endoscopy. The company provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Address

1600 West Merit Parkway, South Jordan, UT, United States, 84095